Anthony T. Reder, MD

Professor of Neurology

The Committees on Neurobiology and Immunology

Dr. Anthony Reder is an expert on multiple sclerosis (MS) and an instrumental faculty member in the University of Chicago Medicine's large MS program.

Dr. Reder and several other colleagues and residents have developed new treatments for MS. The group has shown that misoprostol (Cytotek) abolishes trigeminal neuralgia in MS. The MS group has also helped develop and test most of the current therapies for MS, including Interferon-beta (Betaseron, Avonex, Rebif, Extavia), glatiramer (Copaxone), natalizumab (Tysabri), and fingolimod (Gilenya). The first FDA-approved therapy, IFN-beta (Betaseron), reduced exacerbations of MS and improved memory, and reduced deaths 20 years later by nearly 50 percent. Several other trials of new MS therapies are currently in progress.

Dr. Reder directs the Neurology and Inflammatory Disease Infusion Center. Here, FDA-approved as well as cutting-edge therapies are used to treat multiple sclerosis, lupus, rheumatoid arthritis, sarcoidosis, and Crohn’s disease.

Dr. Reder has authored a large number of papers and abstracts, and often makes presentations at national neurology meetings. Subjects have included multiple sclerosis, EAE, tetanus, neuropsychiatry, sleep, and fatal familial insomnia. His primary research interest is in the interaction between the central nervous system (CNS) and the immune system. He and his colleagues are studying the mechanism of action for interferon--the most widely used treatment for MS. Dr. Reder recently found that there is a defect in the interferon signaling pathway in lymphocytes during attacks and in progressive forms of MS. This may be why patients with progressive MS do not respond clinically to interferon therapy. He was recently awarded a grant from the National MS Society to study the cause of the signaling problem and ways to correct it.

Practice Location

Duchossois Center for Advanced Medicine
5758 S. Maryland Avenue
Chicago, IL 60637

Year Started Practice

1978

Board Certification

Neurology

Medical School

University of Michigan Medical School

Internship

Hennepin County Medical Center, Minneapolis

Residency

University of Minnesota Hospitals, Minneapolis and St. Paul

Memberships

American Academy of Neurology
American Association for Advancement of Science
American Association of Immunology
American Neurological Association
American Society for Neurological Investigation
Association of Medical Laboratory Investigation
Association of University of Professors of Neurology
Brain Research Institute
Chicago Association of Immunologists
International Society for Interferon Research
International Society for NeuroImmunoModulation
Society for Experimental Neuropathology

Language Spoken

English

Office Phone

(773) 702-6204

Office Fax

(773) 702-9076

Office Postal Address

Anthony Reder, MD
The University of Chicago Medicine
5841 S. Maryland Avenue, MC 2030
Chicago, IL 60637

Physician Photo

Clinical Interests

Request an appointment online
or call UCM Connect at
1-888-824-0200

Read More About Dr. Reder

Read about the University of Chicago Medicine's MS program.

Dr. Reder and his colleagues are working to develop "biomarkers" that can distinguish multiple sclerosis from similar neurological diseases. The University of Chicago Medicine's Science Life blog features their work in a post about bringing focus to a blurry diagnosis.

Selected Publications

View a partial list of Dr. Reder's publications through the National Library of Medicine's publication database.